Report Feature
A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global transfection reagent and equipment market report, please download the report brochure.
The study includes trends and forecast for the global transfection reagent and equipment market by product, method, application, end user, and region as follows:
- Reagents
- Equipment
By Method [Value ($ Million) shipment analysis for 2014 – 2025]:
-
Biochemical
- Calcium Phosphate
- Lipofection
- Deae-Dextran
- Dendrimers
-
Physical
- Electroporation
- Nucleofection
- Other Methods
- Viral Methods
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
- Biomedical Research
- Gene Expression Studies
- Cancer Research
- Transgenic Models
- Protein Production
- Therapeutic Delivery
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
- Academics & Research Institutes
- Pharmaceutical & Biotechnology Companies
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Germany
- France
-
Asia Pacific
- China
- India
- Japan
-
The Rest of the World
- Brazil
Some of the transfection reagent and equipment companies profiled in this report include Thermo Fisher Scientific, Promega, Roche, Qiagen, Polyplus-transfection, Bio-Rad Laboratories, Lonza, Sigma-Aldrich, Mirus Bio, and MaxCyte.
Lucintel forecasts that biomedical research will remain the largest application segment over the forecast period due to increasing expenditure on research and development activities by pharmaceutical and biotechnology companies and growing cases of cancer.
Within this market, academic and research institutes will remain the largest end user segment over the forecast period due to increasing research activities related to gene expression, gene silencing studies, and analysis of recombinant proteins.
North America will remain the largest region over the forecast period due to increasing research activities related to bio-based drugs, surge in demand for protein therapeutics, and rising investment for development of biologics in the region.
|
Features of the Global Transfection Reagent and Equipment Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global transfection reagent and equipment market by product (reagents and equipment), method (biochemical (calcium phosphate, lipofection, deae-dextran, and dendrimers), physical (electroporation, nucleofection, and other methods), and viral methods), application (biomedical research (gene expression studies, cancer research, and transgenic models), protein production, and therapeutic delivery), end user (academics & research institutes and pharmaceutical & biotechnology companies), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global transfection reagent and equipment market? Q.5 What are the business risks and threats to the global transfection reagent and equipment market? Q.6 What are the emerging trends in this transfection reagent and equipment market and the reasons behind them? Q.7 What are some changing demands of customers in this transfection reagent and equipment market? Q.8 What are the new developments in this transfection reagent and equipment market? Which companies are leading these developments? Q.9 Who are the major players in this transfection reagent and equipment market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this transfection reagent and equipment market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global transfection reagent and equipment market? |
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Product (Reagents and Equipment), Method (Biochemical, Physical (Calcium Phosphate, Lipofection, Deae-Dextran, and Dendrimers) and Viral Methods (Electroporation, Nucleofection, and Other Methods), and Viral Methods)), Application (Biomedical Research, Protein Production, and Therapeutic Delivery), and End User (Academics & Research Institutes and Pharmaceutical & Biotechnology Companies) |
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
Methodology
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.